是一家专注于国家一类创新生物药开发及产业化的生物制药公司。公司研发核心领域包括肿瘤免疫治疗、代谢性疾病治疗等国内多发病症及目前尚无药可治的疾病领域,并将研发重点放在下一代的双靶点创新生物药。计划在3-5年内建立一条包括8个高端生物新药的产品链,其中包括6个自主创新生物新药和2个引进新药项目
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows